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Protein methylation at arginine residues is a prevalent posttranslational modification in
eukaryotic cells that has been implicated in processes from RNA-binding and transporting to
protein sorting and transcription activation. Three main forms of methylarginine have been
identified: NG-monomethylarginine (MMA), asymmetric NG,NG-dimethylarginine (aDMA),
and symmetric NG,NG-dimethylarginine (sDMA). To investigate gas-phase fragmentations
and characteristic ions arising from methylated and unmodified arginine residues in detail, we
subjected peptides containing these residues to electrospray triple-quadrupole tandem mass
spectrometry. A variety of low mass ions including (methylated) ammonium, carbodiimidium,
and guanidinium ions were observed. Fragment ions resulting from the loss of the correspond-
ing neutral fragments (amines, carbodiimide, and guanidine) from intact molecular ions as
well as from N- and C-terminal fragment ions were also identified. Furthermore, the peptides
containing either methylated or unmodified arginines gave rise to abundant fragment ions at
m/z 70, 112, and 115, for which cyclic ion structures are proposed. Electrospray ionization
tandem mass spectra revealed that dimethylammonium (m/z 46) is a specific marker ion for
aDMA. A precursor ion scanning method utilizing this fragment ion was developed, which
allowed sensitive and specific detection of aDMA-containing peptides even in the presence of
a five-fold excess of phosphorylase B digest. Interestingly, regular matrix-assisted laser
desorption/ionization mass spectra recorded from aDMA- or sDMA-containing peptides
showed metastable fragment ions resulting from cleavages of the arginine side chains. The
neutral losses of mono- and dimethylamines permit the differentiation between aDMA and
sDMA. (J Am Soc Mass Spectrom 2004, 15, 142149) © 2004 American Society for Mass
Spectrometry
Posttranslational modifications of proteins allowthe cell to expand its repertoire beyond the con-straints imposed by the twenty encoded amino
acids. Because many biological processes are controlled
by such modifications, their analysis is an essential step
in the investigation of biological pathways. Arginine
methylation in proteins was discovered over 35 years
ago [1]. The possible functional roles of this modifica-
tion and the characterization of the enzymes involved
have been examined in recent reviews [2, 3]. Two
principal categories of protein arginine methyltrans-
ferases (PRMTs) transfer methyl groups from S-adeno-
syl-L-methionine to the guanidino group of arginine
residues. Both types of enzymes catalyze the formation
of NG-monomethylarginine (MMA) in proteins. Type I
PRMT enzymes also produce asymmetric NG,NG-dim-
ethylarginine (aDMA), whereas Type II enzymes form
symmetric NG,NG-dimethylarginine (sDMA). Type I
substrates include many RNA binding and transporting
proteins, transcription factors, nuclear matrix proteins
and cytokines. Arginine methylation by Type I enzymes
usually occurs in conserved glycine- and arginine-rich
(GAR) sequences, typically in RG or RGG sequences [2,
4]. Myelin basic protein and four spliceosomal proteins
are the only substrates for Type II arginine methyltrans-
ferases reported in the literature [5, 6]. Intriguingly, the
context of methylated residues in these proteins (GRG)
differs from the consensus sequence for asymmetrically
dimethylated proteins. Most PRMT genes discovered to
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date encode for Type I enzymes [3, 7], but recent data
have revealed that PRMT5/JBP1 (Janus kinase binding
protein 1) is a Type II methyltransferase [8]. A novel
modification of arginine residues, -N-methylarginine,
discovered in yeast proteins, indicates that an addi-
tional type of protein arginine methyltransferase exists
in nature [9].
Widely-used methods for detecting and analyzing
the modified residues include the incorporation of
radioactive methyl-3H groups, amino acid analyses,
Edman sequencing and peptide mass mapping by ma-
trix-assisted laser desorption/ionization (MALDI) mass
spectrometry. The Edman sequencing technique and
MALDI mass spectrometry have been utilized for the
location of arginine methylation sites. Amino acid anal-
yses and Edman sequencing allow the differentiation
between asymmetrically and symmetrically dimethyl-
ated arginine residues in principle. In general, trypsin is
the enzyme of choice for generating peptide maps of
known proteins, as well as for proteomics applications.
In trypsin digests of proteins containing either aDMA
and MMA [4] or sDMA and MMA [5], no peptides
resulting from cleavages after modified arginines were
identified. Synthetic peptides containing up to eight
aDMA residues were 4 to 20 times more resistant to
trypsin proteolysis than their non-methylated counter-
parts [10].
In the study reported here, fragmentation pathways
of peptides containing NG-methylated or unmodified
arginine residues were investigated using an electro-
spray ionization (ESI) triple-quadrupole mass spec-
trometer. The sequences of the testpeptides correspond
to arginine methylation sites of nucleolin, an abundant
aDMA-containing protein of the nucleolus [11], and of
myelin basic protein, which carries a single mono-
methylated or symmetrically dimethylated arginine res-
idue [5]. A surprising variety of fragment ions arising
from methylated or even from unmethylated arginines
were identified. Certain fragments observed in the low
energy collision-induced dissociation spectra permit the
unambiguous differentiation between asymmetric and
symmetric dimethylarginine residues. Precursor ion
scanning is a valuable tool for the selective detection of
modified peptides in complex mixtures [12, 13]. We
developed a precursor ion experiment for the sensitive
and selective detection of aDMA-containing peptides.
Dimethylammonium (m/z 46), which was found to be
formed exclusively from this modified amino acid res-
idue, was utilized as “reporter” ion. During final prep-
aration of this manuscript, a report by Rappsilber et al.
appeared that also describes a precursor ion scanning
method for the analysis of arginine dimethylated pep-
tides [14]. Interestingly, some of the fragment ions
observed in the ESI collision-induced dissociation (CID)
spectra appeared as metastable ions in regular MALDI
mass spectra and also permitted the distinction between
the two isomeric forms of DMA.
Experimental
Materials
Peptides GXGGFGGXGGFXGGXGG-NH2 (X: arginine
or aDMA) were synthesized by a solid phase method
using Fmoc chemistry. Fmoc-aDMA(Mts)-OH was syn-
thesized as described [10]. A 30 M solution of these
peptides in 20 mM ammonium bicarbonate buffer, pH
8.0, was cleaved with 1.5% (w/w) chymotrypsin (Roche
Molecular Biochemicals, Basle, Switzerland) for 1 h at
25°C. The chymotryptic cleavage primarily generated
the following fragments: GXGGFGGXGGF and XG-
GXGG-NH2. Glycogen phosphorylase B from rabbit
(Sigma, St. Louis, MO, 100 M) was digested with 1%
(w/w) of modified trypsin (Promega, Madison, WI)
in 1 mM Tris buffer, pH 8.5, at 37°C over night. The
digestion of myelin basic protein from bovine brain
(Sigma; 50 M) with modified trypsin was performed
in 100 mM ammonium bicarbonate buffer, pH 8.0,
and 2 mM CaCl2, at 37°C for 6 h. The MMA- and
sDMA-containing peptides of interest were isolated
by liquid chromatography using a C18 reversed-phase
column (1 mm i.d.  250 mm length) and detected
on-line by ESI mass spectrometry. The concentrations
of the peptides used in the precursor ion scan exper-
iments and of glycogen phosphorylase B were deter-
mined by amino acid analyses using an AminoQuant
II analyzer (Agilent Technologies, Palo Alto, CA)
with fluorescence detection.
Mass spectrometry
ESI mass spectra and tandem mass spectra were re-
corded on an API III triple-quadrupole instrument
(AB/MDS Sciex, Concord, ON, Canada). Mass spectra
and tandem mass spectra were acquired at unit mass
resolution, permitting the distinction between singly
and doubly charged ions. For the acquisition of tandem
mass spectra, argon was used as the collision gas at a
pressure of approximately 2  102 torr. The collision
energy was adjusted for each experiment individually.
In the precursor ion mode, both mass-selective quadru-
poles were optimized for sensitivity at the expense of
some resolution. Precursor ion scans were acquired
with a step size of 0.25 Da and a dwell time of 1.4 ms.
The optimal collision gas pressure was approximately
1.2 102 torr and the collision energy setting was 38 V
(difference between R0 and R2 potentials on the API
III instrument).
MALDI time-of-flight (TOF) mass spectra were re-
corded on a Bruker (Leipzig, Germany) Biflex instru-
ment in the reflector mode employing pulsed ion ex-
traction. The MALDI spectra were calibrated externally
using ion signals from standard peptides. -Cyano-4-
hydroxycinnamic acid (Fluka, Buchs, Switzerland) was
used as the matrix.
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Results
In order to characterize fragment ions and neutral
fragments resulting from unmodified arginine and
from aDMA in detail, the nucleolin-derived peptides
RGGRGG-NH2 and aDMA-GG-aDMA-GG-NH2 were
subjected to MS/MS analysis by ESI triple-quadrupole
mass spectrometry (Figure 1). When subjected to CID,
the peptides yielded surprisingly complex spectra. In
addition to the peptide backbone fragmentation b and y
ion series, a variety of fragment ions and losses of
neutral fragments related to unmodified arginine or
aDMA were identified (Schemes 1 and 2). Typically,
these ions involve one of three cleavages of the gua-
nidino group of the arginine residues.
Relatively intense ion signals arise from loss of
guanidinium ions or of neutral guanidine from the
arginine side chains (Cleavage 1 in Scheme 1). In the
spectrum recorded from peptide RGGRGG-NH2 (Fig-
ure 1a), the signal at m/z 60 corresponds to the guani-
dinium ion (Structure 1 in Scheme 2), and the signal at
m/z 499 is consistent with the singly charged peptide ion
upon loss of guanidinium. Furthermore, formal losses
of the neutral fragments ammonia and guanidine from
the doubly charged precursor ion and from b and y ions
were observed. It is not known if the losses occur from
the precursor with all subsequent losses occurring from
that structure or if the b and y ions directly lose the
small neutrals.
Most amino acid residues give rise to immonium
ions (HN¢CH-R; labeled in a spectrum with the single
letter code of the particular amino acid) with a mass 27
Da lower than that of the amino acid itself [15–17].
However, the regular immonium ion derived from
arginine (m/z 129) is completely absent (Figure 1a).
Instead, arginine residues appear to give rise to several
other low mass ions, the proposed structures of which
are illustrated in Scheme 2. The weak signal at m/z 87
may arise from the loss of carbodiimide from the
immonium ion of arginine (Cleavage 2 in Scheme 1),
which results in the immonium ion of ornithine (Struc-
ture 3). This ion tends to cyclize and concomitantly
release ammonia, leading to the formation of the stable
ion of m/z 70 (Structure 2). Alternatively, a fragment ion
of m/z 70 may be generated by the loss of guanidine
Scheme 1. Chemical structure and side chain fragmentations of
arginine and the methylated arginines studied. Cleavage 1 leads to
guanidines and guanidinium ions, Cleavage 2 to neutral or
protonated carbodiimides, and Cleavage 3 to amines or ammo-
nium ions.
Figure 1. Tandem CID mass spectra (a) of peptide RGGRGG-
NH2 and (b) of peptide aDMA-GG-aDMA-GG-NH2 (5 M each).
Abbreviations: g, guanidine; dma, dimethylamine; dmc, dimeth-
ylcarbodiimide; dmg, dimethylguanidine. The abbreviations in-
clude the corresponding ions.
Scheme 2. Structures proposed for selected fragment ions aris-
ing from unmodified arginines or from aDMA residues in pep-
tides. Analogous fragment ions may be generated from MMA or
from sDMA residues.
144 GEHRIG ET AL. J Am Soc Mass Spectrom 2004, 15, 142149
(Cleavage 1) from the immonium ion of arginine (m/z
129). The signal at m/z 112 can be best explained by a
cyclization of the immonium ion of arginine and accom-
panying loss of ammonia (Structure 4). The abundant
ion at m/z 115 may be best rationalized by the loss of
carbodiimide (Cleavage 2) and subsequent cyclization,
eventually leading to the formation of the Cyclic Ion 5.
Remarkably, intramolecular -N-lactams are frequently
observed as side products resulting from arginine acti-
vation or coupling during peptide syntheses [18].
The low-energy CID spectrum acquired from the
peptide carrying two aDMA residues, aDMA-GG-
aDMA-GG-NH2 (Figure 1b), exhibit two intense peaks
corresponding to dimethylammonium (m/z 46, Struc-
ture 6) and to the peptide ion resulting from the release
of dimethylammonium (m/z 569; Cleavage 3). These
fragment ions and the formal loss of dimethylamine
from b and y ions and from the precursor ion confirm
the presence of the modification and allow to unambig-
uously distinguish between aDMA and sDMA. A peak
of medium intensity at m/z 71 is likely to correspond to
dimethylcarbodiimidium and/or cyano-dimethylam-
monium (Structure 7), and a somewhat more intense
peak arises from dimethylated guanidinium (Structure
8, m/z 88). These two fragment ions are also character-
istic of DMA residues, but they do not permit the
differentiation of its isomeric forms. Dimethylguani-
dine was released primarily as a neutral fragment from
the peptide ion, giving rise to the doubly charged
fragment ion at m/z 264. Prominent signals at m/z 70
(Structure 2) and m/z 115 (Structure 5) and a minor one
at m/z 112 (Structure 4), which are compatible with
aDMA, appeared in the spectrum. Essentially the same
fragmentations were observed in the CID spectra of the
nucleolin-derived peptide GRGGFGGRGGF and of its
aDMA-containing counterpart (data not shown).
Myelin basic protein, which was one of the first
arginine-methylated proteins identified [5], stands in
contrast to most methylated RNA-binding proteins in
that it contains sDMA residues in addition to MMA. To
investigate fragment ions arising from MMA and
sDMA, CID spectra were recorded from peptides G-
MMA-GLSLSR and G-sDMA-GLSLSR, which were ob-
tained by digestion of myelin basic protein with trypsin.
The CID spectrum recorded from the former peptide
(Figure 2a) indicates that the side chains of MMA
residues are rather stable in comparison to sDMA. The
signal at m/z 828 is due to the loss of monomethylam-
monium from the doubly charged peptide ion. The loss
of methylguanidine and monomethylcarbodiimide
from b2 and from the peptide ion as well as the
methylguanidinium ion (m/z 74) were also observed.
The comparison of this MS/MS spectrum to that
acquired from the peptide containing sDMA (Figure 2b)
reveals that the second methyl group further destabi-
lizes the arginine side chain, resulting in more abun-
dant arginine-related fragment ions. The bond between
the internal (or ) nitrogen atom and the carbon atom of
the guanidino group of sDMA is particularly unstable
and susceptible to gas phase fragmentation (Cleavage
2). The CID spectrum recorded from peptide G-sDMA-
GLSLSR shows a fairly intense signal at m/z 71 corre-
sponding to dimethylcarbodiimidium, and the signal at
m/z 803 is consistent with the peptide remaining upon
this cleavage. Other intense peaks can be rationalized
with the formal loss of monomethylamine, dimethylcar-
bodiimide, or dimethylguanidine from a2 or b2 ions.
The fragment ions of m/z 70, 112, and 115 (Scheme 2)
were observed in the CID spectra recorded from the
peptides containing methylarginine or sDMA, too.
However, these fragments were probably formed at
least partially from the C-terminal unmodified arginine
in these peptides.
The common immonium ions and immonium ion
fragments have been identified and are routinely used
in sequencing algorithms [15–17]. High-energy CID
spectra recorded from peptides containing arginine
indicated that ions of m/z 70, 87, 100, 112, and 129 are
diagnostically important low mass fragment ions aris-
ing from this amino acid residue. While the ions at m/z
70, 87, and 112 were actually observed in the low-
energy CID spectrum shown in Figure 1a, the regular
immonium ion of arginine (m/z 129) decayed com-
pletely. The ion at m/z 100 appears to require the
cleavage of a carbon™carbon bond and is probably
formed only under high-energy CID conditions.
The release of guanidine from arginine side chains
Figure 2. Tandem CID mass spectra (a) of peptide G-MMA-
GLSLSR and (b) of peptide G-sDMA-GLSLSR. Abbreviations: S,
immonium ion of serine; L, immonium ion of leucine; g, guani-
dine; mmg, monomethylguanidine; mmc, monomethylcarbodiim-
ide; mma, monomethylamine; dmc, dimethylcarbodiimide; dmg,
dimethylguanidine. The abbreviations include the corresponding
ions.
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was first reported for ESI low-energy CID spectra of
cyclic heptapeptide microcystins [19]. The loss of dim-
ethylamine, guanidine, and dimethylguanidine from a
linear peptide containing both arginine and aDMA was
observed in a CID mass spectrum recorded by an ESI
ion trap instrument [20]. The fragmentation pattern of
the aDMA side chain allowed the unambiguous assign-
ment of the isomeric form of the modified arginine
residue. ESI-MS/MS spectra acquired from the free
amino acid arginine and from its methylated deriva-
tives MMA, aDMA, and sDMA indicated that amines,
carbodiimides and guanidines were released from the
guanidino group [21]. In a recent study conducted on a
quadrupole time-of-flight instrument, DMA-containing
peptides were shown to give rise to five characteristic
fragments: m/z 46 and m/z 71, and neutral loss of 45 for
asymmetric dimethylation and m/z 71 as well as neutral
loss of 70 for symmetric dimethylation [14]. The corre-
sponding signals were much weaker than those ob-
served in this study, and other fragment ions described
here were not identified. It appears that the relativ
intensities of these fragments is dependent both on the
amino acid sequences of the peptides and on the type of
mass spectrometer utilized. Triple quadrupole and hy-
brid quadrupole linear ion trap mass spectrometers are
particularly well suited for the detection of low mass
fragment ions, while quadrupole time-of-flight instru-
ments exhibit some bias against ions of low mass. The
fragment ions described here would typically fall below
the cutoff of ion trap mass spectrometers.
Precursor ion scanning methods are frequently uti-
lized to detect posttranslational protein modifications.
When performing a precursor ion scanning experiment
the mass spectrometer searches for all ions that frag-
ment to produce a common, diagnostic product ion. If
these fragment ions have unique m/z values, peptides
carrying these modifications may be selectively de-
tected by precursor ion scanning within a peptide
mixture using an electrospray tandem mass spectro-
meter. Precursor ion scanning methods have been de-
veloped for phosphorylated amino acids in general [13,
22], for phosphotyrosines [23], for N- and O-linked
glycopeptides [12], for O-GlcNAc-modified peptides
[24], and for various less common protein modifica-
tions.
Here we report a precursor ion scanning experiment
for the specific detection of peptides containing aDMA.
The CID mass spectra presented in Figures 1 and 2
reveal that low mass fragment ions of m/z 70, 112, and
115 are generated from both unmodified and methyl-
ated arginine residues. No sufficiently intense fragment
ion signal that would be specific for MMA was ob-
served in the CID mass spectrum of peptide G-MMA-
GLSLSR. The m/z value of monomethylguanidinium
(m/z 74) corresponds to that of the immonium ion of
threonine. The CID spectra of peptides with aDMA as
well as sDMA exhibit peaks of medium intensity at m/z
71 and 88. However, the m/z value of the dimethylgua-
nidinium ion (m/z 88) coincides with that of the immo-
nium ion of aspartic acid. The fragment ion at m/z 71
may be difficult to differentiate from the heavy isotope
peak of Ion 2 (Scheme 2), which arises from arginine
and proline residues and tends to be very abundant
(Figures 1 and 2). The CID mass spectra recorded from
peptides aDMA-GG-aDMA-GG-NH2 and G-aDMA-
GGFGG-aDMA-GGF indicate that peptides carrying
aDMA give rise to a unique and intense signal at m/z 46.
We investigated the sensitivity and specificity of pre-
cursor ion scanning experiments utilizing this ion as a
characteristic marker of aDMA. Figure 3a shows a
regular ESI mass spectrum recorded from a 1:1 mixture
(mol:mol) of a tryptic digest of phosphorylase B and of
three aDMA-containing test peptides. The spectrum
obtained by precursor of m/z 46 scans is displayed in
Figure 3b. All prominent precursor ion signals are
attributable to the three aDMA-containing peptides,
Figure 3. (a) ESI mass spectrum recorded from a 1:1 mixture (2
M) of a tryptic glycogen phosphorylase B digest and of test
peptides aDMA-GG-aDMA-GG-NH2 (P1), G-aDMA-GGFGG-
aDMA-GGF (P2), and G-aDMA-GGFGG-aDMA-GGF-aDMA-GG-
aDMA-GG-NH2 (P3). (b) Precursor ion scan spectrum of the same
glycogen phosphorylase B/testpeptide mixture obtained by se-
lecting the fragment ion at m/z 46. The minor ion signals at m/z 405
and 532 were assigned to byproducts of the peptide synthesis,
which also contain aDMA. (c) Precursor ion scan spectrum re-
corded from a 5:1 mixture of glycogen phosphorylase B digest (2
M) and of the testpeptides (0.4 M).
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and a few minor signals correspond to related peptide
byproducts. Only the three most abundant peptide ions
at m/z 308, 420, and 541 are observable in the regular
mass spectrum, too. To test the applicability of this
approach to the detection of incompletely dimethylated
arginines, the aDMA peptides were combined with a
fivefold excess of phosphorylase digest, and the mix-
ture was subjected to precursor of m/z 46 scanning
(Figure 3c). Even in this precursor ion scan spectrum, all
major signals could be assigned to aDMA-containing
peptides. These results imply that the precursor ion
scanning experiment based on the marker ion of m/z 46
permits the sensitive and specific detection of aDMA-
containing peptides and that virtually no interfering
peptide-derived fragment ions are found at this m/z
value. This conclusion is in agreement with a recently
published paper of Rappsilber et al. on the detection of
arginine dimethylated peptides by parallel precursor
ion scanning mass spectrometry [14]. The method uti-
lizes two side-chain fragments of DMA of m/z 46
(Structure 6, Scheme 2) and m/z 71 (Structure 7) for
precursor ion scanning on a quadrupole time-of-flight
mass spectrometer. The precursor of m/z 46 scans were
found to be very specific for aDMA-containing pep-
tides, while the m/z 71 scans gave rise to a few signals
which could not be assigned to aDMA- or sDMA-
containing peptides.
Upon MALDI, various carbohydrates [25] and post-
translationally modified peptides [26] form a fraction of
labile molecular ions which lose characteristic frag-
ments after acceleration. Compared to fully accelerated
ions these fragment ions are defocused and give rise to
signals exhibiting reduced resolution and shifted m/z
values in reflector MALDI mass spectra. These metasta-
ble ions are particularly abundant from carbohydrates
carrying sialic acids and from peptides containing phos-
phorylated amino acids, carboxamidomethylated cys-
teines, or methionine sulfoxides.
Interestingly, fragment ions resulting from side-
chain cleavages of DMA in peptides are observable in
MALDI-TOF mass spectra too. A reflector MALDI mass
spectrum recorded from a synthetic peptide containing
four arginine residues, the sequence of which was
derived from nucleolin, displayed only two very weak
signals consistent with metastable losses of ammonia
and carbodiimide (Figure 4a). In contrast, a MALDI mass
spectrum acquired from the corresponding peptide with
four aDMA residues shows a signal of medium intensity
resulting from metastable loss of dimethylamine and a
second signal attributable to two consecutive losses of this
fragment (Figure 4b). In the present study, m/z values of
metastable ions were calculated by using an equation
derived by Harvey et al. [25].
The reflector MALDI mass spectra of peptides G-
MMA-GLSLSR and G-sDMA-GLSLSR confirm that
sDMA is considerably more susceptible to gas phase
fragmentation in comparison to MMA (Figure 5). The
MMA-containing peptide remains virtually intact,
while the MALDI mass spectrum of the peptide with
sDMA displays two signals consistent with the release
of methylamine and dimethylcarbodiimide from the
sDMA side chain. These fragmentation patterns of the
DMA side chains in standard MALDI mass spectra
allow to unequivocally assign the isomeric form of the
modified residues without the acquision of MALDI
Figure 4. MALDI mass spectra recorded from 1 pmol (a) of
peptide GRGGFGGRGGFRGGRGG-NH2 and (b) of peptide G-
aDMA-GGFGG-aDMA-GGF-aDMA-GG-aDMA-GG-NH2, which
contains four aDMA residues.
Figure 5. MALDI mass spectra (a) of peptide G-MMA-GLSLSR
and (b) of peptide G-sDMA-GLSLSR.
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post-source decay or CID spectra. Metastable ions re-
sulting from the loss of dimethylamine can be used as
evidence for the presence of aDMA in the correspond-
ing peptide, while the loss of methylamine is a signa-
ture for sDMA.
Charged side chains of peptides such as the gua-
nidino group of arginine tend to increase signal inten-
sity in MALDI mass spectra [27]. For this reason,
peptides containing modified arginines frequently give
rise to relatively strong ion signals in MALDI spectra
acquired from peptide mixtures, and the metastable
fragment ion signals, which are less intense than the
signals of intact DMA-containing peptides, are often
well discernible even in spectra recorded from complex
peptide mixtures. For example, human RNA-binding
Ewing Sarcoma protein was shown, by using mass
spectrometric peptide mass mapping and sequencing,
to contain at least 29 dimethylated arginine residues [4].
We recorded MALDI mass spectra from trypsin and
chymotrypsin digests of this protein and identified
metastable peaks resulting from loss of dimethylamine,
which indicated the presence of aDMA residues at 22 of
these sites (unpublished data). Interestingly, a MALDI
mass spectrum obtained from a trypsin digest of an-
other methylated protein, SPT5, revealed the presence
of both aDMA and sDMA in a single protein [28], which
was confirmed by other methods.
Asymmetric dimethylation of the guanidinium
group of arginine has several physicochemical effects:
Increased hydrophobicity, a decrease of the hydrogen
bonding ability, and a slightly lower pK value [29]. An
additional effect of NG-methylation is loss of planarity
of the nitrogen atoms in the guanidinium group, prob-
ably due to steric hindrance. This might result in
reduced delocalization energy of the positive charge
and eventually in a decrease in the basicity and also in
the stability of the guanidinium group. The loss of
stability appears to be reflected in increased gas phase
fragmentation of the guanidinium group. Both the
ESI-MS/MS and the MALDI-TOF-MS data indicate that
aDMA residues in peptides rather tend to fragment
compared to monomethylated and unmodified argi-
nines. Similar steric and stereoelectronic effects may
facilitate the observed gas phase fragmentations of
sDMA residues.
Conclusions
The ESI CID mass spectra recorded from peptides
containing unmodified or NG-methylated arginine res-
idues display a variety of fragment ions resulting from
cleavages of the guanidinium group. The ions include
ammonium, carbodiimidium, and guanidinium ions as
well as cyclic ions formed from arginine residues and
peptide ions resulting from loss of neutral or charged
fragments from the arginine side chain. ADMA and
sDMA residues were found to be more prone to frag-
mentation than monomethylated and unmodified argi-
nine. Loss of neutral or protonated dimethylamine and
dimethylguanidine from aDMA and loss of neutral or
protonated dimethylcarbodiimide and dimethylguani-
dine from sDMA are particularly predominant frag-
mentations. (Monomethylated) guanidine and guani-
dinium ions are also released from arginine and MMA
residues. Precursor ion scanning measurements based
on the selection of dimethylammonium as marker ion
permit the specific detection of peptides with aDMA
residues. A promising method for the analysis of this
protein modification is the combination of precursor ion
scanning with the acquisition of MS/MS spectra trig-
gered by the detection of ion signals in the precursor ion
scanning mode. Even MALDI-TOF mass spectra of
peptides carrying aDMA exhibit metastable ion signals
resulting from the loss of dimethylamine. Monomethyl-
amine and dimethylcarbodiimide are released from
sDMA, while monomethylarginine and unmodified ar-
ginine do not give rise to significant metastable ion
signals in MALDI spectra.
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